SI-BONE, Inc. (NASDAQ:SIBN) Insider Anthony J. Recupero Sells 3,670 Shares

SI-BONE, Inc. (NASDAQ:SIBN) insider Anthony J. Recupero sold 3,670 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $13.90, for a total transaction of $51,013.00. Following the sale, the insider now owns 222,814 shares of the company’s stock, valued at $3,097,114.60. This trade represents a 1.62 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link.

SI-BONE Trading Down 1.1 %

Shares of SIBN traded down $0.15 during trading hours on Monday, reaching $14.12. 231,586 shares of the company traded hands, compared to its average volume of 251,762. SI-BONE, Inc. has a 12 month low of $11.70 and a 12 month high of $21.64. The company has a market capitalization of $592.16 million, a price-to-earnings ratio of -15.35 and a beta of 1.16. The company’s fifty day moving average price is $13.58 and its two-hundred day moving average price is $14.14. The company has a quick ratio of 7.22, a current ratio of 8.25 and a debt-to-equity ratio of 0.22.

Hedge Funds Weigh In On SI-BONE

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp increased its stake in shares of SI-BONE by 9.4% during the second quarter. Bank of New York Mellon Corp now owns 142,106 shares of the company’s stock valued at $1,837,000 after purchasing an additional 12,158 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in SI-BONE by 24.7% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,649 shares of the company’s stock valued at $138,000 after buying an additional 2,108 shares in the last quarter. Rhumbline Advisers raised its stake in SI-BONE by 1.5% during the second quarter. Rhumbline Advisers now owns 59,419 shares of the company’s stock valued at $768,000 after buying an additional 852 shares during the last quarter. Arizona State Retirement System boosted its holdings in SI-BONE by 9.0% in the second quarter. Arizona State Retirement System now owns 10,921 shares of the company’s stock worth $141,000 after acquiring an additional 903 shares in the last quarter. Finally, ClariVest Asset Management LLC grew its stake in shares of SI-BONE by 20.7% in the second quarter. ClariVest Asset Management LLC now owns 59,958 shares of the company’s stock worth $775,000 after acquiring an additional 10,274 shares during the last quarter. Hedge funds and other institutional investors own 98.11% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on SIBN. Truist Financial upped their price target on SI-BONE from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Needham & Company LLC reiterated a “buy” rating and issued a $19.00 target price on shares of SI-BONE in a report on Wednesday, November 20th. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $23.00.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.